First scientific presentation of Phase 3 DAYBREAK results for Zenkuda and tabirafusp-ted in wet age-

Three healthcare stocks—Quantum-Si, Kodiak Sciences and Iovance—show overbought RSI readings above 8

Kodiak Sciences NASDAQ: KOD reported that its Phase III DAYBREAK study met primary endpoints for two

Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report) Director Bros. Advisors Lp Baker purchased 33,7

Major U.S. indices closed lower on Monday, with the Dow Jones Industrial Average falling 0.67% to 51

U.S. stocks fell Monday, led by a 150-point Nasdaq drop. Energy rose, communication services slid; K

U.S. stocks fell Monday, while Kodiak Sciences surged 174% after positive Phase 3 eye disease trial

UBS analyst Michael Yee maintains Kodiak Sciences (NASDAQ:KOD) with a Buy and raises the price ta

Gainers Kodiak Sciences (NASDAQ:KOD) shares moved upwards by 172.3% to $88.08 during Monday's r

U.S. stocks fell Monday as the Dow dropped 200+ points; Nasdaq and S&P 500 also slid. Health car

HC Wainwright & Co. analyst Matthew Caufield maintains Kodiak Sciences (NASDAQ:KOD) with a Bu

Regeneron stock drops as Kodiak Sciences reports Phase 3 wAMD data showing Zenkuda rivals Eylea with

Kodiak Sciences announced positive data from its Phase 3 DAYBREAK study for its eye treatments Zenku

Gainers Kodiak Sciences (NASDAQ:KOD) shares increased by 57.4% to $50.93 during Monday's pre-ma

Zenkuda (tarcocimab tedromer) met the primary endpoint (p-value of 0.0007) demonstrating meaningful

Kodiak Sciences to Host Webcast on Monday, September 28 PALO ALTO, Calif., Sept. 25, 2026 /PRNewswir

Goldman Sachs analyst Andrea Newkirk reinstates Kodiak Sciences (NASDAQ:KOD) with a Neutral and a

HC Wainwright & Co. analyst Matthew Caufield reiterates Kodiak Sciences (NASDAQ:KOD) with a B

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

HC Wainwright & Co. analyst Matthew Caufield reiterates Kodiak Sciences (NASDAQ:KOD) with a B

Kodiak Sciences (NASDAQ:KOD) reported quarterly losses of $(1.05) per share which missed the analyst

Phase 3 ALTO trial designed to demonstrate superiority of KSI-501 versus aflibercept in patients wit

JP Morgan analyst Anupam Rama maintains Kodiak Sciences (NASDAQ:KOD) with a Overweight and raises

Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected f

Top analysts upgraded Starz Entertainment, Primoris Services, Pitney Bowes, Kodiak Sciences, and Sta

The small-cap Russell 2000 punched through to an intraday record high on Friday, capping a furious 1

U.S. stocks rise, Dow Jones up 400+ points. PVH Corp beats expectations, shares jump 9.9%. Other big

U.S. stocks lower, Nasdaq falls 1%. Oxford Industries up 11.2% on strong earnings, raised dividend.

The U.S. trade deficit in goods shrank to $87.3 billion in February from $88.6 billion in January, w

Olaplex Holdings shares surge 51% after being acquired by Henkel AG & Co. KGaA. Other big gainer

Dow and NASDAQ down over 0.5%, S&P 500 down 0.82%. Energy shares up, communication services down

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Thursday.

Kodiak Sciences posted a second-quarter loss of $1.03 per share, compared to market estimates of a l

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quart